Month: October 2019

Jaguar Health Announces Completion of Preclinical Studies of Lechlemer, the Company’s Human Drug Product Candidate for Cholera and Acute Infectious Diarrhea

Napo Pharmaceuticals, Jaguar's Subsidiary, Received Preclinical Services from the National Institute of Allergy and Infectious Diseases for the Studies SAN...

error: Content is protected !!